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Human herpesviruses are widespread human pathogens
with a remarkable impact on worldwide public health.
Despite intense decades of research, the molecular de-
tails in many aspects of their function remain to be fully
characterized. To unravel the details of how these viruses
operate, a thorough understanding of the relationships
between the involved components is key. Here, we pres-
ent HVint, a novel protein-protein intraviral interaction
resource for herpes simplex virus type 1 (HSV-1) integrat-
ing data from five external sources. To assess each inter-
action, we used a scoring scheme that takes into consid-
eration aspects such as the type of detection method and
the number of lines of evidence. The coverage of the initial
interactome was further increased using evolutionary in-
formation, by importing interactions reported for other
human herpesviruses. These latter interactions consti-
tute, therefore, computational predictions for potential
novel interactions in HSV-1. An independent experimental
analysis was performed to confirm a subset of our pre-
dicted interactions. This subset covers proteins that
contribute to nuclear egress and primary envelopment
events, including VP26, pUL31, pUL40, and the recently
characterized pUL32 and pUL21. Our findings support a
coordinated crosstalk between VP26 and proteins such as
pUL31, pUS9, and the CSVC complex, contributing to the
development of a model describing the nuclear egress
and primary envelopment pathways of newly synthesized
HSV-1 capsids. The results are also consistent with recent
findings on the involvement of pUL32 in capsid maturation
and early tegumentation events. Further, they open the
door to new hypotheses on virus-specific regulators of
pUS9-dependent transport. To make this repository of
interactions readily accessible for the scientific commu-
nity, we also developed a user-friendly and interactive
web interface. Our approach demonstrates the power of
computational predictions to assist in the design of tar-
geted experiments for the discovery of novel protein-pro-
tein interactions. Molecular & Cellular Proteomics 15:
10.1074/mcp.M116.058552, 2939–2953, 2016.
One important milestone toward understanding the com-
plexity of viral infections is to unravel the interplay between
viral proteins (the intraviral interactome). This is particularly
important for complex and large DNA viruses, such as human
herpesviruses, which have the ability to express a large num-
ber of viral gene-products. For example, the genome of
HSV-1 encodes for more than 75 viral proteins, and the levels
of these proteins are temporally and spatially regulated during
the progression of the viral infection (1). Human herpesviruses
cause life-long infections and many human and animal dis-
eases. The severity of symptoms ranges from cold sores,
genital ulcers, and blisters to blindness and life-threatening
conditions, including fatal encephalitis, meningitis and cancer
(2, 3). Infections from herpesviruses are also a major threat to
immunosuppressed patients (e.g. infected by human immu-
nodeficiency virus) and have been associated with Alzhei-
mer’s disease (3, 4).
Protein interactome studies can reveal critical biological
information and shed light on mechanisms underlying infec-
tious diseases (5), supporting proteome-wide annotation (6, 7)
and the development of therapeutic strategies (8, 9). The
current methods used for building protein-protein interaction
(PPI) networks mainly rely on known interactions and se-
quence analysis (11–13). Recently the field has moved for-
ward through the development of structural and functional
proteomics techniques that include fluorescence microscopy
and Mass Spectrometry (MS)-based approaches (6, 14–16).
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These techniques have helped to increase the coverage of the
interactome in the context of infection. Several public repos-
itories of PPI data exist, such as IntAct (www.ebi.ac.uk/intact/)
(15). Multiple evidence lines, depending on the nature of the
interaction itself and, importantly, the detection method used,
can support each individual PPI. For example, evidence for
PPIs can be derived from biochemical assays, such as Yeast
Two-Hybrid (Y2H), CoImmunoprecipitation (Co-IP)1, in vitro
binding assays, and protein cross-linking, which can be then
analyzed by MS. PPIs can also be derived from Nuclear
Magnetic Resonance (NMR), x-ray crystallography and
Electron Microscopy techniques. Most resources include ev-
idence manually extracted from the literature. Furthermore,
databases that are not explicitly dedicated to storing PPI data
provide additional valuable resources, such as the Protein
Data Bank (PDB www.rcsb.org/) (16) and the Electron Micros-
copy Data Bank (EMDB www.emdatabank.org/) (17), which
contain structural information. Other databases gather PPIs
based on information from multiple resources (e.g. VirHostNet
www.virhostnet.prabi.fr/, STRING-DB http://string-db.org/)
(20, 21). However, constructing a PPI network from disparate
sources while ensuring trustworthiness and high coverage is
challenging. Experiments vary in terms of both reliability and
ability to discriminate between different categories of interac-
tions, notably direct (physical) versus indirect interactions (e.g.
proteins belonging to the same protein complex but without
direct physical contact) as well as transient versus stable
interactions (22). Moreover, for many nonmodel organisms,
the number of known PPIs remains limited, and thus there is
a need to develop hypotheses about additional PPIs that are
not yet supported by direct experimental evidence.
Computational prediction of PPIs (19–23) provide the op-
portunity to maximize the coverage of interaction networks.
These predictions often rely on sequence homology or ma-
chine learning methods (24–26). Several studies have now
illustrated that transferring interaction data between close
homologous species (i.e. interologues mapping (31)) is a suit-
able approach to expand PPI data for a given species. Com-
putational methods for building and analyzing PPI networks
have the potential to identify novel candidates for future ex-
perimental validation, thereby saving valuable time and re-
sources (30, 32, 33).
In this study, we created HVint, a new database for intraviral
PPIs for an important human pathogen, of herpes simplex
virus type 1 (HSV-1, also known as HHV-1), and derived the
associated PPI network. To accomplish this, PPIs reported for
any stage of the “life cycle” were compiled, i.e. interaction
data both for proteins that are incorporated within extracellu-
lar virion particles and proteins that are only expressed in
infected cells has been integrated. Information on the location
of these proteins within the different structural layers of the
virion particle (34, 35), namely the capsid, the tegument and
the viral envelope, was included in the annotation of the
interactions in HVint. To further expand the HVint database,
we integrated the subsets of data from existing databases for
any stage of the virus “life cycle”, implemented a method for
scoring multiple lines of experimental evidence, and incorpo-
rated homologous interactions from the other human herpes-
viruses of the -, -, and -herpesvirus subfamilies. As a
result, our network has significantly higher coverage than
previous HSV-1 networks derived from existing databases
(17, 18, 20, 36, 37), and it predicts novel interactions. We
validated several of these predictions by affinity purifica-
tion-MS using primary human fibroblasts infected with an
HSV-1 virus strain expressing the small capsid protein VP26
tagged with green fluorescent protein (EGFP). Lastly, we de-
veloped a user-friendly interactive web interface, which will
allow the scientific community to readily access and analyze
the interaction data. Taken together, this work demonstrates
the value of data integration and homology transfer in pre-
dicting previously uncovered interactions in a complex virus
such as HSV-1 and in guiding future experimental work.
EXPERIMENTAL PROCEDURES
HVint Data Integration—The PPI data compiled to generate our
novel intra-viral protein interactome includes interactions identified by
a range of experimental methods drawn from multiple sources (Figs.
1 and 2). First, data from four publicly available protein interaction
databases, IntAct (15) (June 2015), VirHostNet 2.0 (18) (June 2015),
Database of Interacting Proteins (DIP) (36) (October 2015) and
BioGRID (37) (October 2015) were collected (38–47). Custom Perl
scripts were used to parse the data and to select “native” interactions
directly reported for HSV-1, and “homologous” interactions originally
reported for any of the other human herpesviruses, i.e. herpes simplex
virus type 2 (HSV-2, HHV-2), varicella-zoster virus (VZV, HHV-3),
Epstein-Barr virus (EBV, HHV-4), human cytomegalovirus (HCMV,
HHV-5), human herpesvirus 6 (HHV-6, A and B), human herpesvirus 7
(HHV-7), or Kaposi’s sarcoma-associated herpesvirus (KSHV, HHV-
8). The search was conducted using taxonomy identifiers (IDs) and all
reported strains for each species were considered. Where possible,
protein IDs, as reported in the above interaction databases, were
mapped to UniProt (48) accession numbers using the UniProt ID
mapping tool (e.g. DIP and BioGRID interactor IDs are from a variety
of databases, including UniProt (48), NCBI RefSeq, and EMBL/Gen-
Bank/DDBJ). In addition we collected interactions derived from struc-
tural evidence provided by the Protein Data Bank (PDB) (16) (June
2015). The taxonomy browser in PDB was used to retrieve entries
1 The abbreviations used are: Co-IP, Co-Immunoprecipitation; PPI,
protein-protein interaction; Y2H, Yeast Two-Hybrid; NMR, nuclear
magnetic resonance; EMDB, Electron Microscopy Data Bank; HSV-1,
HHV-1, herpes simplex virus type 1, human herpesvirus 1; GFP,
Enhanced Green Fluorescent Protein; DIP, Database of Interacting
Proteins; HSV-2, HHV-2, herpes simplex virus type 2, human herpes-
virus 2; VZV, HHV-3, varicella-zoster virus, human herpesvirus 3; EBV,
HHV-4, Epstein-Barr virus, human herpesvirus 4; HCMV, HHV-5,
human cytomegalovirus, human herpesvirus 5; HHV-6, human her-
pesvirus 6; HHV-7, human herpesvirus 7; KSHV, HHV-8, Kaposi’s
sarcoma-associated herpesvirus, human herpesvirus 8; NCBI, Na-
tional Center for Biotechnology Information; EMBL, European Bioin-
formatics Institute; DDBJ, DNA Data Bank of Japan; PDB, Protein
Data Bank; HMM, Hidden Markov model; PSI, Proteomics Standards
Initiative; MI, molecular interactions; CVSC, capsid vertex-specific
component; PFU, plaque forming unit.
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associated with human herpesvirus species. The resultant list was
manually curated to discard entries containing a single protein, and
considered both homo- and hetero-interactions between the compo-
nents. Interactions obtained from this latter data set were also clas-
sified as native (from HSV-1) or homologous (from other human
herpesvirus species) interactions according to their source species.
Homology Transfer of Interactions—Interactions gathered from
other human herpesvirus species were included in HVint only if for a
given interaction both interacting partners in the original species
could be mapped to HSV-1 strain 17 using the homology detection
method described below. This same rationale was also applied to
transfer interactions reported for any other strains of HSV-1 different
from strain 17. Homology relationships were defined based on the
results of HHblits (49) (version 2.0.16). For each of the UniProt protein
IDs involved in homologous species, its FASTA sequence was re-
trieved and used to generate a multiple sequence alignment against
the entire UniProt Hidden Markov model (HMM) database (uni-
prot20_2012_10) with the number of iterations set to 3. An in-house
Perl script was used to extract, where possible, the highest confi-
dence match between the query and a protein in HSV-1 (any strain).
The resulting HSV-1 UniProt IDs were mapped to HSV-1 strain 17
(UniProt reference proteome for HSV1) via UniRef90 clusters (50) with
in-house scripts.
The distribution of the experimental detection methods defining the
interactions in our database is summarized in supplemental Fig. S1.
Y2H methods represent the largest fraction followed by coimmuno-
precipitation techniques, with more than 90% of the interactions
detected so far solely by Y2H experiments. However, about 50% of
the interactions (213 out of 419) are supported by two or more lines of
evidence.
Based on prior knowledge, interactions in the network were also
classified as interactions in the extracellular virions, i.e. taking place in
extracellular viral particles, versus other interactions occurring during
the viral lifecycle based on the classification of each of the interacting
partners (34) (supplemental Fig. S2). All network figures were ren-
dered using Gephi (51).
Scoring of Interaction Data—To measure the confidence of each of
the interactions in HVint, we adapted a heuristic scoring method,
namely MIscore (52, 53). MIscore was chosen because its effective-
ness as a scoring function capable of combining diverse factors that
affect the reliability of molecular interaction data is well established
(53–55). First, scores are assigned to each individual piece of evi-
dence for a given interaction. Aspects such as the interaction detec-
tion method(s), the type of interaction (e.g. colocalization or physical
association) and the number of separate studies reporting the inter-
action, are taken into account. To this end, each evidence line is
rigorously annotated with the PSI-MI ontology (56), a controlled vo-
cabulary developed by the Proteomics Standards Initiative (PSI) (57)
for the standardization of molecular interaction (MI) annotation data
(example tags are, MI:009 for “protein complementation assay” and
MI:0428 for “imaging technique”). Next, scores from different lines of
evidence are brought together to compute a single value per interac-
tion. A more detailed description of MIscore can be found in (53). In
our study, we modified the original MIscore function. The evidence
inferred from homology was scaled according to the sequence iden-
tity between HSV-1 and the corresponding homologs, as follows:
given a pair of interacting sequences A and B and their HSV-1
homologs A and B, the original (unmodified) MIscore was multiplied
by a scaling factor s defined as:
S 1 if P  40; p/40 otherwise}
where p is min{sequence identity between A and A, sequence iden-
tity between B and B}. In other words, the score was scaled accord-
ing to the lowest percentage identity between either of the interact-
ing partners with their respective homologs. Here 40% was chosen
as a conservative cut-off, taking into account prior studies of ho-
mology and the conservation PPIs between related species (53).
The resulting modified MIscore scores range between 0 and 1
(supplemental Fig. S3).
Network Analysis—We next assessed how filtering out interactions
based on MIscore cut-offs affected the network topology by mea-
suring how several network properties varied as interactions with a
score below a certain cut-off were removed from the network. Self-
interactions were not considered during this analysis, as they do not
affect most of the network properties under study. We also analyzed
how the network changes when separating direct versus indirect
interactions according to the PSI-MI classification.
Experimental Validation by Affinity Purification-Mass Spectrome-
try—We used the HSV1(17)blueLox-GFPVP26 strain, here denoted
HSV1-GFPVP26, in which the small capsid protein VP26 has been
tagged at the N terminus with EGFP (58). As a control, we used the
HSV1(17)blueLox-pMCMVGFP strain, here denoted HSV1-GFP,
which expresses EGFP alone, under the control of the murine cyto-
megalovirus promoter, inserted between the UL55 and UL56 ORFs
(59). The viruses were propagated, isolated, and titered in Vero cells
(ATCC CCL81) grown in DMEM containing 10% FBS and 1% peni-
cillin/streptomycin, as previously described (60, 61). Primary human
foreskin fibroblast cells (HFFs) were infected with HSV-1 strains at 1
plaque forming unit per cell (pfu/cell) for fluorescence microscopy or
5 pfu/cell for immunoaffinity purification-MS studies. The immunoaf-
finity purifications of GFPVP26 or EGFP during productive HSV-1
infection were accomplished using magnetic beads conjugated with
in-house generated rabbit anti-GFP antibodies, as previously de-
scribed (60, 62). However, for the present work, the HSV-1 strain
background was 17, and not KOS as in our previous work. Further-
more, to capture additional interactions, we selected a cell lysis/
immunoisolation buffer of intermediate stringency, namely 20 mM
HEPES-KOH, pH 7.4, containing 0.11 M potassium acetate, 2 mM
MgCl2, 0.1% Tween 20, 1 M ZnCl2, 1 M CaCl2, 0.75% Triton X-100,
200 mM NaCl, 0.2% deoxycholate, and 1/100 v/v protease inhibitor
mixture (Sigma). The immunoaffinity purifications of GFPVP26 and
GFP were each performed in three biological replicates.
After immunoisolation of GFPVP26 and its interacting partners, the
proteins were separated ( 3 cm) by SDS-PAGE using a 4–12%
Bis-Tris NuPAGE gel (3 cm), then stained with Coomassie blue and
cut into gel slices. Gel slices were pooled to maintain approximate
equal protein amounts (based on Coomassie blue staining) and di-
gested in-gel with trypsin, as described (60). Extracted peptides from
neighboring gel fractions were pooled (n  6 fractions), desalted
using SDB-RPS StageTips (63), concentrated to near dryness, then
resuspended in 10 l of 0.1% formic acid and analyzed by nanoliquid
chromatography-tandem MS (nLC-MS/MS).
Briefly, peptides (4 l) were separated by reverse phase chroma-
tography-nLC (Acclaim PepMap RSLC, 1.8 m  75 m x 50 cm) at
a flow rate of 250 nL/min over a 90 min ACN gradient from 4–40%
mobile phase B (A, 0.1% FA; B, 97% ACN in 0.1% FA) and ionized by
ESI directly into the mass spectrometer (LTQ Orbitrap Velos equipped
with an EASY-Spray ion source). The mass spectrometer was oper-
ated in a data-dependent acquisition mode. Each acquisition cycle
comprised a single full-scan mass spectrum (m/z  350–1700) in the
orbitrap (r  30,000 at m/z  400) followed by CID MS/MS of the top
15 most abundant ions, with dynamic exclusion enabled.
MS/MS fragmentation spectra were extracted and peptide spec-
trum matches were obtained using Proteome Discoverer (ver. 1.4)/
SEQUEST (ver 1.3) by searching independently against the forward
and reverse subset of the human UniProt-SwissProt database (2013–
08) appended with herpesvirus sequences and common contami-
nants (22,910 sequences). SEQUEST search parameters were de-
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fined as the following: full trypsin specificity, maximum of 2 missed
trypsin cleavages, ion precursor mass tolerance of 10 ppm, fragment
ion mass tolerance of 0.5 Da, fixed modification of cysteine carbam-
idomethylation, variable modifications of methionine oxidation, and
serine, threonine, and tyrosine phosphorylation. The Proteome Dis-
coverer workflow also included the precursor ions area detector node
for MS1-based label-free quantification. Database search results
were analyzed in Scaffold (ver. 4.6, Proteome Software, Inc) using the
LFDR algorithm and a refinement search using the X! Tandem algo-
rithm (Beavis Informatics), which specified the following additional
modifications using the same search parameters as above: deamida-
tion of glutamine and asparagine, acetylation of protein N termini. The
global peptide and protein FDR were controlled to  1%, estimated
by reverse database search matches. The MS proteomics data have
been deposited to the ProteomeXchange Consortium via the PRIDE
(64) partner repository with the data set PXD003599 and 10.6019/
PXD003599 identifier. Unweighted protein spectrum counts and cor-
responding precursor area quantitative values were exported to Excel
and additional filtering of the protein identifications was performed.
Briefly, protein groups with  10 spectra in at least two out of three
replicates were retained. For proteins identified in both GFPVP26 and
the GFP controls, the spectral count fold enrichment was calculated
for each biological replicate as the ratio of the spectral counts in each
GFPVP26 replicate and the averaged GFP samples. Viral proteins
with an average enrichment ratio of  fivefold were retained. The
Top3 precursor area method, which uses the three most intense
peptides as a measure of protein concentration (65), was used to
estimate the stoichiometry of viral proteins coisolated with GFPVP26.
Fluorescence Microscopy—Primary human fibroblast cells were
cultured as described above, except on glass cover slips, and in-
fected with HSV1-GFPVP26 at a multiplicity of infection of 1 pfu/cell.
At 14 h postinfection, cells were fixed with 2% (v/v) paraformaldehyde
in PBS for 15 min at room temperature and prepared for imaging as
previously described (60). Nuclei were stained with DAPI. The sub-
cellular localization of GFPVP26 was analyzed using a confocal mi-
croscope (Leica SP5) equipped with a 100x oil-immersion lens.
Experimental Design and Statistical Rationale—The HVint database
was populated with non-redundant PPI data collated from five differ-
ent public resources (IntAct, VirHostNet 2.0, DIP, BioGRID and PDB).
In doing so, we distinguished between two different sets of PPI data:
(1) PPIs directly reported in HSV-1 and (2) PPIs reported in other
human herpesviruses species. HHblits was used to establish orthol-
ogy-relationships between proteins interacting in homologous human
herpesviruses and HSV-1 proteins. When HSV-1 homologous pro-
teins were detected for both interacting partners in the source spe-
cies, the interaction was transferred to the HSV-1 interactome and
included in the HVint database. All PPI data in HVint was scored
under the MIscore scheme, a heuristic scoring method designed to
capture the heterogeneity of PPI data. MIscore is computed taking
into account the annotation data for a given interaction. This annota-
tion is defined by the HUPO PSI controlled vocabulary, which has
been implemented by the public database members of the IMEx
consortium (56). The final normalized scores result from the weighted
sum of three different terms representing (1) the number of different
citations reporting the interaction, (2) the corresponding detection
method(s) used, and (3) the nature of the interaction (type). An earlier
study compared the performance of MIscore with that of the normal-
ized score implemented in Mentha, a large integrative database (not
containing viral interactomes) with over 570,000 PPIs (66). It was
tested on a benchmark of 500 high confidence human PPIs (positive
data set) and 397 noninteractions extracted from Negatome (negative
data set) (67). Around the optimal score cut-offs for each database
(0.485 for MIscore, 0.343 for the Mentha score) MIscore was shown to
have greater accuracy, precision, and recall than the Mentha score
(0.76 versus 0.67, 0.70 versus 0.66 and 0.98 versus 0.85, respectively)
(53). Our predicted interactions transferred from other human herpes-
viruses were scaled down from their originally assigned MIscore
according to the sequence identity of each interacting protein to its
corresponding HSV-1 homolog. The resulting scores take values
between 0 and 1 (inclusive), with larger values reflecting higher con-
fidence in the interaction. This calibrated scale was designed to allow
users to fine-tune the selection of PPI data subsets in the database,
based on their research purposes.
A subset of computationally predicted interactions was selected as
potential candidates for experimental validation by IP-MS. To identify
this subset, we studied how several parameters characterizing the
topology of the interactome changed when interactions scoring below
a given MIscore threshold were removed from the network. The
changes in network parameters were assessed in the entire range
between 0 to 1 MIscore thresholds, in steps of 0.1. The IP-MS
experiments isolating HSV1-GFPVP26 were performed in three bio-
logical replicates and compared against three biological IP-MS rep-
licates of HSV1-GFP. In total six biological samples were subjected to
GeLC-MS/MS analysis.
RESULTS
HVint Interactome—The computational and experimental
pipeline developed in this work (see Experimental Proce-
dures, Fig. 1) resulted in a novel HVint interactome (Fig. 2).
The data fed into the pipeline originated from five different
resources (IntAct, VirHostNet, DIP, BioGRID, and PDB) (Figs.
1 and 3). PPIs reported for HSV-1 and all of the other human
herpesvirus species currently known (herpes simplex virus
type 2, varicella-zoster virus, Epstein-Barr virus, human cyto-
megalovirus, human herpesviruses 6 and 7, and Kaposi’s
sarcoma-associated herpesvirus) were collected. The latter
interactions were transferred to the HSV-1 interactome only
when orthologs for both interacting partners in the source
species (e.g. HCMV) could be found in the HSV-1 proteome.
The resulting network comprises 73 nodes and 419 PPIs
(including 36 self-interactions), the reliability of which was
assessed with a modified MIscore function (see Methods).
The confidence values for the interactions in the network
range from 0.147 to 0.972. Confidence values were computed
using a highly integrative and experimentally based scoring
scheme that takes into account the type of interaction and
detection method used to detect the interaction, as well as the
number of different studies providing support for the interac-
tion. Interactions were divided into two different data sets
according to the source species: native interactions (reported
in HSV-1) and homologous interactions (transferred from an-
other human herpesvirus species). Homologous interactions
(255 in total) account for 55% of the network, hence signif-
icantly increasing the size of the network beyond that of the
native network (Fig. 4A). Twenty-nine interactions are present
in both native and homologous PPI data sets, indicating con-
servation of PPIs between two or more herpesvirus species.
These conserved herpesvirus PPIs involve 50 of the HSV-1
proteins, which correspond to about 70% of the HSV-1 pro-
teome (Fig. 4B). 98% (413) of these interactions were classi-
fied as “direct interaction” or “physical association” by the
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PSI-MI annotation, meaning the respective experimental con-
ditions indicate that this interaction either involves direct
physical contact or that or the molecules are in close
proximity.
New Interactions—Predicted PPIs that so far have not been
supported by experimental evidence are of particular interest,
as they point to putative biological mechanisms yet to be
confirmed. To investigate whether such predicted PPIs in-
deed exist for HSV-1, a subset of high confidence homolo-
gous interactions was subjected to experimental validation.
This subset was selected from the interactions in HVint having
a confidence score greater than 0.4. The rationale behind this
cutoff was that the initially observed topological properties of
the interactome were barely altered for confidence score cut-
offs in the range between 0 and 0.4 (supplemental Fig. S4),
but for cut-offs between 0.4 and 0.5 drastic changes in sev-
eral network parameters (including clustering coefficient, cen-
tralization, density, and average node degree) were observed.
This calculated MIscore threshold is consistent with previ-
ously reported estimates of optimal cut-offs for scores pre-
dictions, within the range of 0.4 to 0.5 (53). We then retained
PPIs derived from homology predictions only (i.e. only in the
homologous data set). By definition, these homology-based
PPIs have been reported for other human herpesviruses but
not yet for HSV-1.
The resulting data set, referred hereafter as high-confi-
dence homologous interactions subset, comprises a total of
35 interactions (30 hetero-interactions and 5 self-interactions)
among 28 different proteins (Fig. 5, supplemental Table S1).
28 hetero-interactions out of the 30 are connected in a single
connected component, i.e. a group of nodes in which a path
can be traced for any random pair of nodes (68). These
interactions involve 23 proteins that have been annotated as
being involved mainly in transcription, capsid assembly, and
nuclear capsid egress events (supplemental Table S2). The
two binary interactions outside the main graph involve the
obligate hetero-dimer gH/gL, an essential component of
the herpesvirus entry machinery (69), and the tegument pro-
teins pUL7 and pUL51. The minor capsid protein pUL25 is
also present in the data set with only one self-interaction. It is
worth emphasizing that these disconnected components are
nevertheless connected to the rest of the network when the
whole interactome is considered (i.e. without filtering interac-
tions). Our HVint interactome highlighted envelope protein
pUS9 to be a hub for several potential interactions. Its pre-
dicted first neighbors, including VP26 (pUL35), the major
small capsid protein (SCP), pUL17, another minor-capsid pro-
tein that interacts with pUL25, and the inner tegument protein
pUL36, that are known to function in capsid structure, matu-
ration, and tegument association (70–74). As the function of
these proteins has not been studied in the context of pUS9-
mediated virion maturation and transport, they represent
promising targets for future investigation.
Validation of New Interactions—To assess the informative
value of our novel PPI network (Fig. 5), we first searched the
published literature for experimental evidence that had not
been used as an input to our HVint (i.e. has yet to be incor-
porated within one of our source databases). We found recent
experimental evidence supporting a complex formation of
tegument proteins pUL7 and pUL51; coimmunopurification
followed by MS detected this interaction, which was then
confirmed and functionally characterized (75).
FIG. 1. Workflow of the procedure to generate and process protein-protein interaction data for the HVint database.
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Second, we conducted affinity purification MS-based pro-
teomics experiments. From the homology-based network, we
selected VP26 (pUL35) for affinity purification from a produc-
tive HSV-1 infection as a respective replication-competent
GFP-tagged virus was available (76). Primary human fibro-
blast cells were infected with HSV1-GFP or HSV1-GFPVP26,
which are HSV-1 (17) strains expressing EGFP alone (con-
trol) or EGFP-tagged VP26, respectively (c.f. Experimental
Procedures and (76)). Wide field fluorescence microscopy
was used to determine the subcellular localization of GF-
PVP26 following infection (Fig. 6). We focused on 14 h post
infection (p.i.), a relatively late time point in infection when
under our experimental conditions capsid and virus assembly
are in progress (Fig. 6C). Thus, this represents the stage of
infection when VP26 is predominantly nuclear, and expected
to interact with other capsid components. Additionally, at this
stage, capsids containing VP26 are also starting to undergo
nuclear export, and thereby expected to associate with pro-
teins involved in capsid egress. Both of these subsets of
interactions, capsid-associated and nuclear egress proteins,
were part of our predicted VP26 interactions (Fig. 5). The GFP
tag was used for affinity isolation of GFPVP26 using specific,
high-affinity anti-GFP antibodies under relatively stringent
conditions (60).
The immuno-isolated proteins from cells infected with
HSV1-GFP or HSV1-GFPVP26 were digested with trypsin and
analyzed by liquid chromatography-tandemMS. Viral proteins
detected with at least fivefold greater spectral counts in
HSV1-GFPVP26 compared with the HSV1-GFP control im-
muno-isolations were considered high confidence candidate
interactions (supplemental Table S3). Although VP26 was iso-
lated here using another HSV-1 strain and different lysis con-
ditions when compared with a previous study ((60); c.f. Ex-
perimental Procedures), 90% of the enriched interaction
FIG. 2. Circular layout of the novel PPI network. The respective node size indicates the number of interacting partners for each protein
(degree). The edge width is scaled according to the confidence score associated with the interaction. Nodes are color-coded according to the
respective protein location in the virion particles - gray: protein has not been detected in virions by MS in Loret et al. 2008 (34); cyan - capsid
or capsid-associated protein; orange - tegument protein; yellow - envelope glycoprotein; dark blue - other envelope protein (not glycoproteins).
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candidates were the same, pointing to reproducible findings.
Importantly, our experiment confirmed two of the three pre-
dicted direct PPIs of VP26, specifically with pUL31 and pUL40
(Fig. 6D, red edges). The third predicted association with
pUS9 was the only predicted direct association not detected
under these lysis conditions so far. However, we cannot ex-
clude the possibility that pUS9 is a bona fide interaction that
was not maintained in the applied lysis buffer. Given the
relatively small size of US9 (10 kDa and 90 amino acids), its
detectability by mass spectrometry would be more challeng-
ing than either pUL31 or pUL40. In fact, an in silico tryptic
digestion of HSV1 US9 predicts only 1 - 3 tryptic peptides
to be detected under our instrument configuration and
methodology.
Because immuno-affinity purification of GFPVP26 is ex-
pected to also identify indirect interacting partners, the pro-
FIG. 3. Venn diagram showing the total number of non-redun-
dant PPIs in the source public databases, i. e. IntAct (6–2015),
VirHostNet (VHN; 6–2015), Database of Interacting Proteins (DIP;
10–2015), BioGRID (10–2015), and PDB (6–2015). Numbers in pa-
rentheses refer to the total number of interactions originating from
each source database. Numbers inside the colored areas indicate the
degree of overlap between data sets. Empty subsets indicate zero
overlap.
FIG. 4. A, Venn diagram showing the total number of non-redundant PPIs in the novel HVint database classified as native and
homologous interactions, respectively. The numbers in parenthesis refer to the total number of PPIs; the numbers inside the circles indicate
the degree of data set overlap. B, Venn diagram showing the number of non-redundant proteins involved in PPIs in the HVint database.
Proteins are involved in native and/or homologous interactions. The numbers in parenthesis refer to the number of non-redundant proteins in
the respective data set with the numbers inside the circles indicating the degree of data set overlap.
FIG. 5. Subnetwork highlighting homologous PPIs with a MIs-
core > 0. 4 (supplemental Table S2). The node size indicates the
number of interacting partners for each protein (degree). Edge width
is scaled according to the confidence score associated with the PPI.
The nodes are color-coded according to the protein location in the
virion particles - gray: protein has not been detected in virions by MS
in Loret et al. (34); cyan - capsid and capsid-associated protein;
orange - tegument protein; yellow - envelope glycoprotein; dark
blue - envelope protein (not glycoprotein).
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teins coisolated with GFPVP26 were compared with the pre-
dicted, second order VP26 interactions (via pUL40 and
pUL31, see Fig. 5). Indeed, the IP-MS experimental data set
identified the proteins pUL32, pUL18, pUL26, pUL52, pUL21,
and pUL10 (gM). Binary interactions between pUL40 and
each of pUL32, pUL18, pUL26, and pUL52, as well as be-
tween pUL31 and each of pUL26, pUL21 and gM are pre-
dicted by our high-confidence homologous HVint subnetwork
(MIscore 	 0.4). Additionally, the interaction between pUL31,
a nuclear egress protein, and pUL32, a protein suggested to
contribute in efficient localization of newly synthesized cap-
sids to nuclear replication compartments and DNA packag-
ing, is present in our homology-transferred data set but with
scores below the 0.4 cut-off. Overall, the experimental im-
muno-affinity purification experiments provide compelling
support for the homologous HVint network.
Interactive Web-based HVint Interface—All the data in
HVint, including pairwise interactions, lines of evidence, and
scores, are available for download in a standard format for
molecular interactions data, namely PSI-MITAB 2.5. Addition-
ally, we provide a user-friendly and intuitive interface to
browse the data in a more straightforward and intuitive man-
ner (http://topf-group.ismb.lon.ac.uk/hvint). The HVint inter-
face displays an interactive graphical representation of the
network and allows easy access to annotation data for indi-
vidual nodes and edges. These can be selected by clicking on
them or, in the case of nodes, specifying their UniProt ID in the
provided search tool. The subnetwork created by the first
neighbors of the selected element is then presented, together
with its associated data (including a list of interactions, con-
fidence scores and supporting evidence) in tabular form.
Other functionality of the interface includes the ability to filter
interactions based on user-defined confidence thresholds.
DISCUSSION
HVint was originally populated with data from five major
external public resources. Although some overlap exists in the
data coming from these databases, each contributes multiple
unique interactions. A recurrent issue in interactomics studies
is the lack of network coverage, which severely limits the
informative power of the resulting networks (77, 78). There-
fore, in retrieving data from the five resources, we distin-
guished between two data sets. One data set contained na-
tive interactions reported as directly detected for HSV-1, and
the second one was composed of homologous interactions
detected in any of the other human herpesvirus species,
covering all three herpesvirus subfamilies. The latter data set
was then used to predict PPIs in HSV-1 based on orthology
relationships between the interacting partners in the homolo-
gous species and HSV-1 proteins. Integrating these data in-
creased the network coverage by more than twofold. More
importantly, it provides a set of putative novel interactions to
be validated in HSV-1. To provide a measure of the quality
and reliability of the data in the database, we implemented the
FIG. 6. Validation of homologous PPIs by IP-MS. A, Schematic of
the HSV-1 (strain 17) genome indicating the locus (UL35 gene) that
encodes for GFP-tagged VP26. B, Experimental design for IP-MS val-
idation of predicted VP26 protein interactions. Primary human fibro-
blasts were infected with HSV1 GFP or HSV1 GFPVP26, then collected
and cryogenically lysed. GFPVP26 and control GFP were immuno-
affinity purified from cell lysates using -GFP antibodies conjugated to
magnetic beads. Coisolated proteins were eluted from the beads and
resolved by SDS-PAGE, followed by nLC-MS/MS analysis. C, Fluores-
cence microscopy of human foreskin fibroblasts infected with HSV1-
GFPVP26. The cellular localization of GFP-tagged VP26 was visualized
by direct fluorescence (green) at 14 h post-infection (hpi). Nuclei were
stained by DAPI (blue). Scale bar 20 m. D, The HVint subnetwork of
homologous predicted PPIs (Fig. 5) was annotated to indicate PPIs that
were coisolated with VP26 (pUL35) by IP-MS. Both direct (red edges)
and indirect, secondary (blue edges) PPIs are highlighted.
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MIscore (53) scoring function in our protocol. MIscore inte-
grates data from multiple experiments that report a given
interaction to calculate an overall confidence score, which is
normalized to the interval [0, 1]. It calculates weighted scores
based on key variables: experimental detection method(s)
(e.g. biophysical, imaging), type of interaction (e.g. physical
association, colocalization), and number of different scientific
publications reporting it. In our implementation we gave lower
weighting to orthology-transferred interactions by penalizing
their original score in a sequence-identity dependent manner.
An advantage of implementing this scoring scheme was that
it yielded a calibrated series of scores (ranging from 0 to 1),
which allowed for fine-tuned selection of sets of interactions
based on their confidence levels. We used this approach to
select a subset of high-confidence interactions for further
experimental testing.
Overall, our interactome, including 419 interactions,
achieved a notably larger coverage than any individual source
database alone. This set is split between 195 native and 255
homologous interactions, with a small subset of them over-
lapping between the two (31 interactions), and it covers all 77
proteins in the HSV-1 reference proteome (as reported in
UniProt (48)). The data integration framework used in this
study (Fig. 1) is automated and relatively simple, which will
allow future updates to be implemented easily as new inter-
action data becomes available.
The prevalence of Y2H experiments in protein-protein in-
teraction studies (79) is reflected in the large fraction of inter-
actions obtained by this method in HVint (90%, 380 inter-
actions). This is because of the ability of Y2H experiments to
determine physical pairwise interactions between potentially
interacting partners, and from the feasibility of conducting
both small- and large-scale screenings. Since the publication
of the first large-scale protein interactions map for S. cerevi-
siae in 2000 (80), multiple studies have followed and several
caveats have been raised regarding the interpretation and
reliability of Y2H data, especially when obtained from high-
throughput screenings (81). The main concern is the larger
false positive and false negative rates than in previous tradi-
tional small-scale approaches. This has demanded a contin-
ued optimization of the technique (as shown in recent reports
(79, 81–83)), and the development of a range of alternative
hybrid strategies to complement Y2H data sets (79). These
approaches have minimized the error rate in more recent data,
suggesting that in the future the reliability of Y2H data could
be assessed on a per data set basis in the future. HVint
includes data derived from Y2H experiments across a broad
period of time. Consequently, we could not yet, at present,
systematically assess the quality of each data set (as this is
not reflected in the source databases). The use of MIscore as
a scoring method is advantageous in this respect; it assigns
comparatively low scores to interactions detected by Y2H
experiments, thereby representing a conservative approach in
assessing the confidence of these interactions.
To test the predictive power of our computationally derived
interaction data set, we subjected a subset of PPIs with
high-confidence scores to experimental validation. To this
end, a number of homologous-only interactions that scored
above 0.4 were selected. We focused our own validation
analysis on VP26 (encoded by UL35), because it is a protein
whose functions are still unclear, and because several HSV-1
strains in the F, 17 and KOS background have been gener-
ated, in which VP26 has been successfully tagged with fluo-
rescent proteins without or with minor impairment of HSV-1
propagation (58, 60, 84–87). Hexamers of VP26 are located
on top of the capsid hexons, which are hexamers of VP5, but
not on the pentons, which are pentamers of VP5. VP26 is
therefore perfectly placed on the capsid surface for interac-
tions with other viral and cellular components (74, 76, 88, 89).
Mutants of pseudorabies virus (PRV), a porcine -herpesvirus,
or of HSV-1, that lack VP26, are less neuroinvasive and neu-
rovirulent and grow to lower titers than their respective pa-
rental strains (85, 90–92). VP26 can interact with the dynein
light chains of the Tctex family in Y2H and coIP experiments.
However, it is not required for efficient dynein-mediated trans-
port toward the nucleus during cell entry, and dynein does not
bind to un-tegumented capsids that expose VP26 over their
entire surface (74, 76, 84, 93). Homologous small capsid
proteins of other herpesviruses have been shown to contrib-
ute to capsid stability (94, 95).
Our HVint homologous subnetwork predicts that VP26 is
associated with pUL31 and pUL40 (Fig. 7). This is supported
by our experimental immuno-affinity isolation studies. VP26 is
present in the mature virion particle, whereas pUL31 and
pUL40 are not part of it (34, 88, 89, 96–99). Hence these
interactions may be particularly relevant in understanding the
role of VP26 in the viral life cycle. Notably, VP26 was also
coisolated with pUL34, one of the known binding partners of
pUL31 (supplemental Table S3). Together, pUL31 and pUL34
form the so-called nuclear egress complex, which is anchored
to the inner nuclear membrane by the C-terminal domain of
pUL34 and faces the nuclear lumen (99, 100). Given the
conservation of the interaction between pUL31 and pUL34
and their respective orthologs across the entire Herpesviridae
family (101), many studies have explored their roles in the
early steps of the capsid assembly and the nuclear egress
pathway. Besides being recruited directly to pUL34 at the
inner nuclear envelope, pUL31 has also been reported to
interact via its N-terminal domain to newly synthesized nu-
clear capsids (102). The pUL31-bound capsids are then
thought to be translocated to the inner nuclear membrane,
where they associate via UL31 with pUL34 to mediate capsid
egress from the nucleoplasm to the cytosol (102). Overall, the
localization of VP26 to the capsid surface except the vertices,
its documented roles in capsid trafficking, and our computa-
tional and experimental findings of VP26 association with
nuclear egress and CVSC complexes, suggests an as yet
unknown role for VP26 in enforcing capsid stability and coor-
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dinating intra-nuclear capsid trafficking events (Fig. 7). Fur-
ther, the recent in situ analyses of the NEC architecture re-
vealed a curved hexagonal lattice for PRV (103, 104). As
pUL31 and pUL34 are highly conserved in the Herpesviridae
this architecture is highly likely to be evident in HSV-1 as well.
Therefore, an attractive hypothesis is that VP26 hexamers and
pUL31/34 hexamers interact directly with each other. Future,
in situ analysis will need to show whether this is in fact the
case.
Another pair of viral proteins, pUL39 and pUL40, which
constitute the small and the large subunits (RR1 and RR2,
respectively) of the heterotetrameric HSV-1 ribonucleotide
reductase complex (105–108), were also coisolated with VP26
by IP-MS analysis. Intriguingly, the latter was also predicted
to interact with VP26 in our homologous subnetwork. In ad-
dition to this enzymatic function, several studies have high-
lighted a role for pUL39 as a virulence factor (106, 108–110),
for instance by interfering with apoptotic cascades (106, 109–
111). This again suggests a potential role for VP26 in the early
events of virus replication. Our experimental validation sup-
ports the interaction between VP26 via pUL40 to pUL39 and
further to each of pUL32, pUL18 (VP23) and one or more
products of the HSV-1 UL26 gene, which encodes for an
autocatalytic protease that is processed into the scaffold
proteins VP24 and VP21 (112, 113). Notably, all these inter-
actions have been predicted in our homologous subnetwork.
Further, a recent study has provided new insights into a
possible role of pUL32 as a chaperone-like protein capable of
modulating capsid maturation and tegument acquisition by
interacting with the capsid proteins pUL6 (the portal protein),
pUL25, and pUL38 (VP19c) as well as the inner tegument
protein pUL36 (114).
Among the membrane proteins, our HVint interactome pro-
vides a particularly high number of novel interactions for
pUS9. pUS9 is a small type II membrane protein of about 10
kDa that localizes to the trans-Golgi network and axonal ves-
icles of neuronal cells (115–117). Our HSV-1 interactome pre-
dicts interactions between pUS9 and the capsid proteins
VP26 and pUL17, as well as the inner-tegument protein
pUL36. pUL17 and pUL25 form the Capsid Vertex-specific
FIG. 7. Novel interactions predicted by HVint and supported by IP-MS experiments (Fig. 6) in the context of the viral life cycle. Proteins
are color-coded according to the protein location in the virion particles - gray: protein has not been detected in virions by MS in Loret et al.
2008 (34); cyan - capsid and capsid-associated protein; orange - tegument protein; yellow - envelope glycoprotein. Solid lines indicate
predicted interactions in HSV-1 with MIscore 	 0.4; dashed lines indicate predicted interactions with MIscore  0.4. Both direct (red edges)
and indirect, secondary (blue edges) PPIs are highlighted.
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component (CVSC) located on the pentons edges and pUL17
and pUL25 are both required for stable DNA packaging into
capsids prior to nuclear egress (70, 118, 119). pUL36 is an
inner protein known to be involved in early tegumentation
events together with its binding partner pUL37 (72, 84). Like
the CVSC, the complex pUL36-pUL37 is also located around
penton vertices. Interestingly, PPIs and coordinated events
between pUL36-pUL37 and CVSC have been previously
shown (72). Together with the heterodimer gE/gI, pUS9 me-
diates anterograde axonal transport of viral tegument, glyco-
proteins, and virions of -herpesviruses in neurons, but these
proteins are not essential for replication in epithelial or fibro-
blasts cells (40–42). Although studies on the gE/gI and pUS9-
mediated transport of PRV structures show that PRV is trans-
ported along axons as fully assembled virions in transport
vesicles, the data on HSV-1 regarding the subviral and viral
particles being targeted to axons is still controversial (116,
117, 120). Because the HSV-1 or PRV proteins that might
contribute to these differences are not known, our novel pre-
dicted interactions from HVint generate new hypotheses on
potentially virus-specific regulators of US9-dependent an-
terograde transport.
The nodes outside the main cluster of the 35 new interac-
tions involve those forming two heterodimers conserved
across the entire Herpesviridae family, namely gH/gL and
pUL51-pUL7, and one self-interaction for pUL25. The com-
plex gH/gL was structurally solved in HSV-2 by x-ray crystal-
lography in 2010 (121). Given the high confidence of the
experimental data and the degree of sequence similarity be-
tween HSV-1 and HSV-2 gH/gL sequences, the existence of
this complex in HSV-1 is undisputed (121–123). Although its
specific role is yet to be fully defined, it is likely involved in
regulating the activity of the membrane fusion glycoprotein gB
(121).
Finally, complex formation between pUL51 and pUL7, as
predicted in our HVint database, was confirmed recently by
affinity purification and tandem MS experiments (75). At the
time of writing, these data were not integrated into the source
PPI databases used in this work. pUL51 and pUL7 are both
conserved across the whole Herpesviridae family. pUL51 is an
N terminus membrane-anchored tegument protein (124–126)
with no apparent enzymatic function, suggested to play a role
in viral egress, viral envelopment and epithelial cell-to-cell
spread (127, 128). Its interaction with pUL7 seems to be
required for efficient recruitment of the latter to cytoplasmic
membranes leading to its incorporation into the virion. Both
proteins partially colocalize in cytoplasmic membranes to-
gether, as observed in the case of pUS9, with glycoprotein gE
(128). This implies that the complex is non-obligate and each
protein could carry out independent functional activities.
pUL7 was also found inside the nuclear and cytoplasmic
compartments in the absence of pUL51, and interactions
between pUL7 and capsid proteins have been reported. As in
the case of pUS9, the complex between pUL51 and pUL7
supports the idea that viral membrane proteins are principal
agents in tegumentation and secondary envelopment pro-
cesses. By establishing interactions with capsid and capsid-
associated proteins they guide progeny virion particles to
different cytoplasmic compartments (e.g. trans Golgi network
or endosomes) until they reach the plasma membrane (42,
129–134).
CONCLUSIONS
Here we introduce the HVint database, an integrative re-
source for HSV-1 protein interaction data. The database con-
tains interactions experimentally detected in HSV-1 species
and computationally predicted using evolutionary information.
Interactions in the database have been scored, thus confi-
dently providing novel predicted interactions. Consequently,
HVint can be used as a tool to prioritize candidate interac-
tions for future experimental testing. The protocol used to
create and populate the database was kept simple, hence
facilitating database updates. In the future, our aim is to
further improve our methods for assessing the reliability of
protein interaction data and to include more advanced fea-
tures in the HVint graphical interface to accommodate
users’ needs. We also plan to extend the current database
to other human herpesvirus species and to virus-host
interactions.
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